Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection

We are developing an associated vaccine based on live influenza vaccine (LAIV) and streptococcal recombinant peptides. The recombinant group B streptococcus (GBS) peptides P6 and ScaAB demonstrated a distinguished immunomodulating effect in THP-1 cells. The increase in IFN 1-alpha expression after S...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Yulia A. Desheva, Galina F. Leontieva, Tatiana A. Kramskaya, Galina O. Landgraf, Ivan A. Sychev, Andrey R. Rekstin, Alexander N. Suvorov
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2019-02-01
Rangatū:	Heliyon
Ngā marau:	Immunology Microbiology Vaccines Virology
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2405844018326446
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!